BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 30904172)

  • 1. Changes in total thyroidectomy versus thyroid lobectomy for papillary thyroid cancer during the past 15 years.
    James BC; Timsina L; Graham R; Angelos P; Haggstrom DA
    Surgery; 2019 Jul; 166(1):41-47. PubMed ID: 30904172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
    Zhao H; Huang T; Li H
    Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent of surgery for low-risk thyroid cancer in the elderly: Equipoise in survival but not in short-term outcomes.
    Zambeli-Ljepović A; Wang F; Dinan MA; Hyslop T; Stang MT; Roman SA; Sosa JA; Scheri RP
    Surgery; 2019 Nov; 166(5):895-900. PubMed ID: 31288935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.
    Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
    Surgery; 2017 Feb; 161(2):485-492. PubMed ID: 27593085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
    Ebina A; Sugitani I; Fujimoto Y; Yamada K
    Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and Outcomes of Surgical Management of Primary Papillary Carcinoma in the Pediatric Population.
    Sharma RK; Huang B; Lee JA; Kuo JH
    J Surg Res; 2021 Jul; 263():207-214. PubMed ID: 33690052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of lobectomy for papillary thyroid carcinoma with high-risk features.
    Xu S; Huang H; Wang X; Liu S; Xu Z; Liu J
    Br J Surg; 2021 Apr; 108(4):395-402. PubMed ID: 33793787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis.
    Liu J; Zhang Z; Huang H; Xu S; Liu Y; Liu S; Wang X; Xu Z
    Oral Oncol; 2019 Mar; 90():17-22. PubMed ID: 30846171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of needing completion thyroidectomy for low-risk papillary thyroid cancers treated by lobectomy.
    DiMarco AN; Wong MS; Jayasekara J; Cole-Clark D; Aniss A; Glover AR; Delbridge LW; Sywak MS; Sidhu SB
    BJS Open; 2019 Jun; 3(3):299-304. PubMed ID: 31183445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
    Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
    Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total Thyroidectomy vs Thyroid Lobectomy for Localized Papillary Thyroid Cancer in Children: A Propensity-Matched Survival Analysis.
    Memeh K; Ruhle B; Alsafran S; Vaghaiwalla T; Kaplan E; Angelos P; Keutgen XM
    J Am Coll Surg; 2021 Jul; 233(1):39-49. PubMed ID: 33887483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total vs hemithyroidectomy for intermediate risk papillary thyroid cancer: A 23 year retrospective study in a tertiary center.
    Tsui KP; Kwan WY; Chow TL
    Am J Otolaryngol; 2019; 40(3):431-434. PubMed ID: 30956005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems.
    Adam MA; Thomas S; Hyslop T; Scheri RP; Roman SA; Sosa JA
    J Clin Oncol; 2016 Dec; 34(36):4415-4420. PubMed ID: 27998233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer.
    Semrad TJ; Keegan THM; Semrad A; Brunson A; Farwell DG
    Thyroid; 2018 Sep; 28(9):1143-1152. PubMed ID: 29929451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment.
    Krook KA; Fedewa SA; Chen AY
    Laryngoscope; 2015 Apr; 125(4):1021-7. PubMed ID: 25583017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
    Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
    J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The optimal surgical approach for papillary thyroid carcinoma with pathological n1 metastases: An analysis from the SEER database.
    Ji T; Chen J; Mou J; Ni X; Guo Y; Zhang J; Wang S; Wang W; Zhang X; Tai J
    Laryngoscope; 2020 Jan; 130(1):269-273. PubMed ID: 30953386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Diagnostic Dilemma: Skip Metastasis in Papillary Thyroid Cancer.
    Özden S; Çomçalı B; Ataş H; Er S; Tez M; Saylam B
    Am Surg; 2020 Mar; 86(3):245-249. PubMed ID: 32223805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.